Article Details

Novartis to pay $310 million for assets from inflammation specialist IFM

Retrieved on: 2019-03-31 14:43:35

Tags for this article:

Click the tags to see associated articles and topics

Novartis to pay $310 million for assets from inflammation specialist IFM. View article details on hiswai:

Excerpt

<div>IFM Therapeutics is part of the portfolio of Cambridge, Massachusetts-based <b>Atlas Venture</b>, whose other stakes include Intellia Therapeutics that is ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up